U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases announces the availability of funding for implementation of the HIV Vaccine Vector-Host Interactions: Understanding the Biology and Immunology (R21) Exploratory/Developmental Research Grant. The purpose of this grant is to develop improved safety models to assess the potential vaccine-related effects such as increased HIV infection rates due to immune activated vector-specific HIV target cells. The R21 activity code is intended to encourage new exploratory and developmental research projects. Contractors should refer to Section VII, Agency Contacts, in the . . .

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

RFP | May 13, 2014

Federal Government Announces HIV Vaccine Vector-Host Interactions: Understanding the Biology and Immunology (R21) Exploratory/Developmental Research Grant Funding

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member